TCL Archive Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says August 19, 1994
TCL Archive NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period October 18, 1985
TCL Archive Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies June 25, 2010
TCL Archive In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director January 27, 1978
TCL Archive Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.” November 3, 2006
